相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis
Luca Prosperini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis
Katharine Harding et al.
JAMA NEUROLOGY (2019)
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
Dalia Rotstein et al.
NATURE REVIEWS NEUROLOGY (2019)
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
J. William L. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Unraveling treatment response in multiple sclerosis A clinical and MRI challenge
Claudio Gasperini et al.
NEUROLOGY (2019)
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
Georgina Arrambide et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
Georgina Arrambide et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Reporting treatment outcomes in observational data: A fine balance
Tomas Kalincik et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Reporting treatment outcomes in observational data: A fine balance
Tomas Kalincik et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial
Zhongheng Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Regression coefficient-based scoring system should be used to assign weights to the risk index
Hemalkumar B. Mehta et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Assessing response to interferon-β in a multicenter dataset of patients with MS
Maria Pia Sormani et al.
NEUROLOGY (2016)
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis
Mar Tintore et al.
NEUROLOGY (2016)
Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
Emer Fogarty et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Defining high, medium and low impact prognostic factors for developing multiple sclerosis
Mar Tintore et al.
BRAIN (2015)
BREMSO: a simple score to predict early the natural course of multiple sclerosis
R. Bergamaschi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Aggressive multiple sclerosis: proposed definition and treatment algorithm
Carolina A. Rush et al.
NATURE REVIEWS NEUROLOGY (2015)
Multiple sclerosis-a quiet revolution
Richard M. Ransohoff et al.
NATURE REVIEWS NEUROLOGY (2015)
EVIDENCE-BASED GUIDELINES MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients
Mike P. Wattjes et al.
NATURE REVIEWS NEUROLOGY (2015)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Scoring treatment response in patients with relapsing multiple sclerosis
M. P. Sormani et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Refining response to treatment as defined by the Modified Rio Score
M. P. Sormani et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Defining and scoring response to IFN-β in multiple sclerosis
Maria Pia Sormani et al.
NATURE REVIEWS NEUROLOGY (2013)
Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic
Ebru Erbayat Altay et al.
JAMA NEUROLOGY (2013)
Brainstem lesions in clinically isolated syndromes
M. Tintore et al.
NEUROLOGY (2010)
Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis
Richard A. Rudick et al.
LANCET NEUROLOGY (2009)
Measures in the first year of therapy predict the response to interferon β in MS
J. Rio et al.
MULTIPLE SCLEROSIS (2009)
Clinical prognostic factors in multiple sclerosis: a natural history review
Alexandra Degenhardt et al.
NATURE REVIEWS NEUROLOGY (2009)
Predicting responders to therapies for multiple sclerosis
Jordi Rio et al.
NATURE REVIEWS NEUROLOGY (2009)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
M. Tintore et al.
NEUROLOGY (2008)
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score
Roberto Bergamaschi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
New natural history of interferon-β treated relapsing multiple sclerosis
Maria Trojano et al.
ANNALS OF NEUROLOGY (2007)
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
J Río et al.
ANNALS OF NEUROLOGY (2006)
Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
R Bergamaschi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
分享论文
